Overview
Your “Big Picture” Endocrinologist:
As a physician with specialized training and experience in endocrinology, diabetes, and metabolism, I recognize the human body’s complex nature, where organs and their functions are deeply intertwined. To broaden my understanding and address patents’ diverse health aspects, I pursued additional board certifications in lipidology, hypertension, and obesity medicine. These certifications are closely linked to endocrinology and play pivotal roles in overall health.
Through this expanded knowledge base, I have developed a unique skill set in the realm of integrative endocrinology. This cross-disciplinary expertise empowers me to not only attend to my patients’ specific hormonal needs but also to take a holistic approach to their overall well-being. By addressing the interconnected relationships among various bodily organs, I aim to provide more effective and personalized care that transcends isolated medical symptoms. In short, this approach allows me to consider the broader context of my patients’ health, resulting in a more thorough and integrated endocrine care experience.
Beyond Symptoms:
When you choose me as your doctor, I move beyond simply assessing and treating isolated symptoms. Instead, I focus on uncovering the underlying or “hidden” factors contributing to your condition. I do this by considering the dynamic interplay between various hormones, metabolic processes, and bodily organs, all of which influence your well-being.
Dr. Tashko is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Abdominal Obesity Metabolic Syndrome, Type B Insulin Resistance Syndrome, Mitochondrial Complex V Deficiency, and Cytochrome C Oxidase Deficiency.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
15204 Omega Dr Ste 240, Rockville, MD 20850
Additional Areas of Focus
Dr. Tashko has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.
Center For Diabetes And Endocrine
Olufunmilayo Onobrakpeya is an Endocrinologist in Bel Air, Maryland. Dr. Onobrakpeya is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Thyroid Nodule, and Paget's Disease of Bone.
UM Center For Diabetes And Endocrinology At UM BWM
Kristin Flammer is an Endocrinologist in Glen Burnie, Maryland. Dr. Flammer is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Diabetic Nephropathy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Abdominal Obesity Metabolic Syndrome
- Cytochrome C Oxidase DeficiencyDr. Tashko isAdvanced. Learn about Cytochrome C Oxidase Deficiency.
- Familial HypopituitarismDr. Tashko isAdvanced. Learn about Familial Hypopituitarism.
- HypothyroidismDr. Tashko isAdvanced. Learn about Hypothyroidism.
- Mitochondrial Complex V Deficiency
- Type 1 Diabetes (T1D)Dr. Tashko isAdvanced. Learn about Type 1 Diabetes (T1D).
- Experienced
- Acute Mountain SicknessDr. Tashko isExperienced. Learn about Acute Mountain Sickness.
- Addison's DiseaseDr. Tashko isExperienced. Learn about Addison's Disease.
- Adrenal Gland AdenomaDr. Tashko isExperienced. Learn about Adrenal Gland Adenoma.
- Anaplastic Thyroid CancerDr. Tashko isExperienced. Learn about Anaplastic Thyroid Cancer.
- Cushing's syndromeDr. Tashko isExperienced. Learn about Cushing's syndrome.
- Cushing's syndrome due to Adrenal TumorDr. Tashko isExperienced. Learn about Cushing's syndrome due to Adrenal Tumor.